Kumuds4d ago

Recombinant Human Erythropoietin Injection Market to Grow at 3.8% CAGR by 2032

Get the Complete Report & Table of Contents: https://www.24lifesciences.com/recombinant-human-erythropoietin-injection-market-14067

#Erythropoietin
#rhEPO
#AnemiaTreatment
#BiologicsMarket
#PharmaceuticalMarket
#Hematology
#KidneyDisease
#OncologyTherapy
#BiotechIndustry
#HealthcareMarket

Kumuds5d ago

Hydroxycamptothecin for Injection Market to Reach USD 420 Million by 2032 | CAGR 4.8%

Get the Complete Report & Table of Contents: https://www.24lifesciences.com/hydroxycamptothecin-for-injection-market-14025

#Hydroxycamptothecin #OncologyDrugs #CancerTreatment #Chemotherapy #PharmaceuticalMarket #OncologyResearch #CancerTherapy #TopoisomeraseInhibitor #PharmaIndustry #HealthcareMarket #LifeSciences #MedicalResearch #GlobalHealth #Biopharma #24LifeSciences

EURACTIV HealthNov 21, 2024
Bitter tensions in Slovak healthcare growing, still no deal between ministry and unions https://www.euractiv.com/section/health-consumers/news/bitter-tensions-in-slovak-healthcare-growing-still-no-deal-between-ministry-and-unions/?utm_source=dlvr.it&utm_medium=mastodon #PharmaceuticalMarket
Bitter tensions in Slovak healthcare growing, still no deal between ministry and unions

Privatisation fears, funding gaps and administrative pressures have led to doctors' en masse resignation threa

EURACTIV
EURACTIV HealthJul 9, 2024
European agreements with pharma can push development and production, says Belgian MEP Vautmans [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/european-agreements-with-pharma-can-push-development-and-production-says-belgian-mep-vautmans/?utm_source=dlvr.it&utm_medium=mastodon #PharmaceuticalMarket
European agreements with pharma can push development and production, says Belgian MEP Vautmans

A staunch advocate for the European Health Union, Belgium's Hilde Vautmans begins her third MEP mandate with a

EURACTIV
EURACTIV HealthJul 9, 2024
Poland leans towards shorter data exclusivity period, one year market protection [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/poland-leans-towards-shorter-data-exclusivity-period-one-year-market-protection/?utm_source=dlvr.it&utm_medium=mastodon #PharmaceuticalMarket
Poland leans towards shorter data exclusivity period, one year market protection

Warsaw has sided with the European Commission on the length of the Regulatory Data Protection (RDP) period in

EURACTIV
EURACTIV HealthJun 18, 2024
Strike by Swedish health workers escalates as holiday season approaches [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/strike-by-swedish-health-workers-escalates-as-holiday-season-approaches/?utm_source=dlvr.it&utm_medium=mastodon #PharmaceuticalMarket
Strike by Swedish health workers escalates as holiday season approaches

Massive healthcare protests continue across Sweden, with 3,300 healthcare workers on strike, operations cancel

EURACTIV
EURACTIV HealthMay 14, 2024
Hungary’s ageing health system suffering traumatic personnel loss https://www.euractiv.com/section/health-consumers/news/hungarys-ageing-health-system-suffering-traumatic-personnel-loss/?utm_source=dlvr.it&utm_medium=mastodon #PharmaceuticalMarket
Hungary's ageing health system suffering traumatic personnel loss

The professional standards of Hungarian healthcare providers are under scrutiny following the introduction of

EURACTIV
EURACTIV HealthApr 22, 2024
Decrease in data protection period risks medicine price increase, says Greek health minister https://www.euractiv.com/section/health-consumers/news/decrease-in-data-protection-period-risks-medicine-price-increase-says-greek-health-minister/?utm_source=dlvr.it&utm_medium=mastodon #PharmaceuticalMarket
Decrease in data protection period risks medicine price increase, says Greek health minister

The Greek government is firmly opposed to any changes to the duration of the regulatory protection period (RDP

EURACTIV
EURACTIV HealthFeb 5, 2024
Greek start-up receives funding to develop treatments for protein misfolding diseases https://www.euractiv.com/section/health-consumers/news/greek-start-up-receives-funding-to-develop-treatments-for-protein-misfolding-diseases/?utm_source=dlvr.it&utm_medium=mastodon #PharmaceuticalMarket
Greek start-up receives funding to develop treatments for protein misfolding diseases

ResQ Biotech has become the first Greek company to receive a European Research Council Proof of Concept Grant

EURACTIV
EURACTIV HealthFeb 5, 2024
Swedish stakeholders worried about European Health Data Space costs https://www.euractiv.com/section/health-consumers/news/swedish-stakeholders-worried-about-european-health-data-space-costs/?utm_source=dlvr.it&utm_medium=mastodon #PharmaceuticalMarket
Swedish stakeholders worried about European Health Data Space costs

Adoption of the European Health Data Space regulation is expected soon, and Sweden is scrambling to prepare fo

EURACTIV